Yikilmaz TN, Dirim A, Ayva ES, Ozdemir H, Ozkardes H. Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin. Urol J [Internet]. 2016 Jun. 28 [cited 2024 May 2];13(3):2677-83. Available from: https://journals.sbmu.ac.ir/urolj/index.php/uj/article/view/3294